SLC9A3 and diabetic kidney disease: Studies in rodents with diabetic kidney disease showed a 40% increase in basal renal oxygen consumption, attributed to tubular hypertrophy, gluconeogenesis, and compensatory increase in the number of SGLT and NHE3 transporters.